News

Kenvue appoints Kirk Perry as interim CEO, sees Q2 adjusted EPS of $0.28 to $0.29
Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut ...
Fierce Pharma1h
Consumer health giant Kenvue kicks off CEO transition as sales slip
With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...
Barchart on MSN20h
Tylenol-Maker Kenvue Launches Turnaround Plans. How Should You Play KVUE Stock Here?
Kenvue shares (KVUE) are in focus Monday after the consumer health firm ousted its CEO, Thibaut Mongon, and announced a ...
Kenvue: New CEO, Watch The Dividend (Rating Downgrade)
“The Board’s strategic review is underway, and we are considering a broad range of potential alternatives, including ways to ...
Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors
All that culminated on Monday with the abrupt resignation of Kenvue CEO Thibaut Mongon, his replacement by board director ...
Renuncia CEO de Kenvue mientras la empresa sigue con su revisión estratégica
Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con ...
Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood
The maker of Tylenol and Benadryl named director Kirk Perry as interim chief executive. Shares rallied over 5% before t ...